A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Enprofylline
Antithrombin III human
The risk or severity of bleeding can be increased when Antithrombin III human is combined with Mitoxantrone.
Enprofylline
Protein C
The risk or severity of bleeding can be increased when Protein C is combined with Mitoxantrone.
Enprofylline
Antithrombin Alfa
The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Mitoxantrone.
Enprofylline
Zinc citrate
The risk or severity of bleeding can be increased when Zinc citrate is combined with Mitoxantrone.
Enprofylline
Desirudin
The risk or severity of bleeding can be increased when Desirudin is combined with Mitoxantrone.
Enprofylline
Parnaparin
The risk or severity of bleeding can be increased when Parnaparin is combined with Mitoxantrone.
Enprofylline
Bemiparin
The risk or severity of bleeding can be increased when Bemiparin is combined with Mitoxantrone.
Enprofylline
Dextran
The risk or severity of bleeding can be increased when Dextran is combined with Mitoxantrone.
Enprofylline
Sodium citrate
The risk or severity of bleeding can be increased when Sodium citrate is combined with Mitoxantrone.
Enprofylline
Potassium citrate
The risk or severity of bleeding can be increased when Potassium citrate is combined with Mitoxantrone.
Enprofylline
Ditazole
The risk or severity of bleeding can be increased when Ditazole is combined with Mitoxantrone.
Enprofylline
Nadroparin
The risk or severity of bleeding can be increased when Nadroparin is combined with Mitoxantrone.
Enprofylline
Ferulic acid
The risk or severity of bleeding can be increased when Ferulic acid is combined with Mitoxantrone.
Enprofylline
Tinzaparin
The risk or severity of bleeding can be increased when Tinzaparin is combined with Mitoxantrone.
Enprofylline
Dalteparin
The risk or severity of bleeding can be increased when Dalteparin is combined with Mitoxantrone.
Enprofylline
Danaparoid
The risk or severity of bleeding can be increased when Danaparoid is combined with Mitoxantrone.
Enprofylline
Amediplase
The risk or severity of bleeding can be increased when Amediplase is combined with Mitoxantrone.
Enprofylline
Otamixaban
The risk or severity of bleeding can be increased when Otamixaban is combined with Mitoxantrone.
Enprofylline
Astaxanthin
The risk or severity of bleeding can be increased when Astaxanthin is combined with Mitoxantrone.
Enprofylline
Idraparinux
The risk or severity of bleeding can be increased when Idraparinux is combined with Mitoxantrone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3